Momenta Pharmaceuticals, Inc.

Agilix Corporation

Kevin J McConnell

Brian T Chait

Paul M Lizardi

Ishan Capila

Leona E Ling

Darin R Latimer

Matthew E Roth

Jon S Morrow

Thomas Prod'homme

Victor Farutin

Martin J Mattessich

Eric R Kershnar

Described herein are methods for treating rheumatoid arthritis by determining whether a subject having rheumatoid arthritis will respond to an anti-TNF-alpha therapy based on the number of innate and adaptive immune cells in a sample from the subject prior to treatment.

Methods for predicting response to treatment

Disclosed are compositions and methods for sensitive detection of one or multiple analytes. In general, the methods involve the use of special label components, referred to as reporter signals, that can be associated with, incorporated into, or otherwise linked to the analytes. In some embodiments, the reporter signals can be altered such that the altered forms of different reporter signals can be distinguished from each other. In some embodiments, sets of reporter signals can be used where two or more of the reporter signals in a set have one or more common properties that allow the reporter signals having the common property to be distinguished and/or separated from other molecules lacking the common property. In other embodiments, sets of reporter signal/analyte conjugates can be used where two or more of the reporter signal/analyte conjugates in a set have one or more common properties that allow the reporter signal/analyte conjugates having the common property to be distinguished and/or separated form other molecules lacking the common property. Reporter signals can also be in conjunction with analytes (such as in mixtures of reporter signals and analytes), where no significant physical association between the reporter signals and analytes occurs; or alone, where no analyte is present.

Ultra-sensitive detection systems using alterable peptide tags

Growing community of inventors

Branford, CT, United States of America

Kevin J McConnell